eGFR vs Framingham CardioRisk
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
eGFR
Calculate glomerular filtration rate (GFR) using various formulas for different age groups. Provides information on kidney disease classification and risk minimization. Always consult a doctor for medical decisions.
- GFR calculation
- Schwartz formula for children
- CKD-EPI, MDRD, Cockcroft formulas
- Information on kidney disease
- Risk minimization guidance
Read full descriptionHide full description
As an important parameter for assessing kidney function, the glomerular filtration rate, or GFR, is widely used. With the eGFR app, you can calculate an estimated glomerular filtration rate (eGFR) based on serum creatinine. For children and adolescents up to 18 years of age, the Schwartz formula is available. For adults, the CKD-EPI, MDRD and Cockcroft-Gault formulas can be used depending on the desired calculation. In addition, the app provides background information on the individual formulas, guidance on the interpretation of GFR values, and information on risk reduction. The eGFR app is intended solely for calculation and informational purposes and does not replace medical diagnosis, advice or treatment. Medical decisions should not be made solely on the basis of the information provided in the app. In case of health concerns, abnormal values, or before making medical decisions, medical advice should be sought.
Framingham CardioRisk
Read full descriptionHide full description
The Framingham Scale allows to determine the risk of suffering any cardiovascular event in 10 years, assessing factors such as age, sex, blood pressure, diabetes, and smoking, assigning a score to each of them and stratifying the patient in low, medium, and high cardiovascular risk. It also allows to calculate the vascular age, which gives an estimate of the vascular damage of the patient through the variation of years between it and its chronological age. Made for healthcare professionals. Do not use for self-diagnosis. Seek a doctor’s advice.
Screenshots
Verdict
eGFR and Framingham CardioRisk are too close to call on the numbers: across 5 compared parameters — price, ads, in-app purchases and device support among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | eGFR | Framingham CardioRisk |
|---|---|---|
| Price | Free | Free |
| Rating | 4.8 (4 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 4 — better | — |
| Update frequency | Fortnightly | — |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad | iPhone, iPad |
| Requires iOS | 16.4 | 16.0 — better |
| Further details — not scored | ||
| Size | 35 MB | 1 MB |
| Age rating | 17+ | 17+ |
| Developer | Christian Schramm | Gabriel Ernesto Martinez Canepa |
In-app purchases
eGFR
No in-app purchases
Framingham CardioRisk
No in-app purchases









